
Walter E. Webb
Examiner (ID: 5438, Phone: (571)270-3287 , Office: P/1612 )
| Most Active Art Unit | 1612 |
| Art Unit(s) | 1612, 4133 |
| Total Applications | 1277 |
| Issued Applications | 576 |
| Pending Applications | 113 |
| Abandoned Applications | 605 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 7168507
[patent_doc_number] => 20050202049
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-09-15
[patent_title] => 'Retinoid-containing preparations'
[patent_app_type] => utility
[patent_app_number] => 10/515636
[patent_app_country] => US
[patent_app_date] => 2003-07-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3946
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0202/20050202049.pdf
[firstpage_image] =>[orig_patent_app_number] => 10515636
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/515636 | Retinoid-containing preparations | Jul 15, 2003 | Abandoned |
Array
(
[id] => 5040257
[patent_doc_number] => 20070092539
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-04-26
[patent_title] => 'Method of preparing an aqueous meloxicam solution and aqueous solution thus produced'
[patent_app_type] => utility
[patent_app_number] => 10/564271
[patent_app_country] => US
[patent_app_date] => 2003-07-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1763
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0092/20070092539.pdf
[firstpage_image] =>[orig_patent_app_number] => 10564271
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/564271 | Method of preparing an aqueous meloxicam solution and aqueous solution thus produced | Jul 9, 2003 | Abandoned |
Array
(
[id] => 5743670
[patent_doc_number] => 20060089395
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-04-27
[patent_title] => 'Nf-kb activation inhibitors'
[patent_app_type] => utility
[patent_app_number] => 10/516294
[patent_app_country] => US
[patent_app_date] => 2003-06-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 70632
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0089/20060089395.pdf
[firstpage_image] =>[orig_patent_app_number] => 10516294
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/516294 | Nf-kb activation inhibitors | Jun 4, 2003 | Abandoned |
Array
(
[id] => 5632332
[patent_doc_number] => 20060148802
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-07-06
[patent_title] => 'Use of compounds that stimulate cgmp'
[patent_app_type] => utility
[patent_app_number] => 10/516778
[patent_app_country] => US
[patent_app_date] => 2003-05-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3691
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0148/20060148802.pdf
[firstpage_image] =>[orig_patent_app_number] => 10516778
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/516778 | Use of compounds that stimulate cgmp | May 29, 2003 | Abandoned |
Array
(
[id] => 5851764
[patent_doc_number] => 20060234955
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-10-19
[patent_title] => 'Cardiac glycosides to treat cystic fibrosis and other il-8 dependent disorders'
[patent_app_type] => utility
[patent_app_number] => 10/515260
[patent_app_country] => US
[patent_app_date] => 2003-05-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 12910
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0234/20060234955.pdf
[firstpage_image] =>[orig_patent_app_number] => 10515260
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/515260 | Cardiac glycosides to treat cystic fibrosis and other il-8 dependent disorders | May 27, 2003 | Abandoned |
Array
(
[id] => 5648496
[patent_doc_number] => 20060134228
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-06-22
[patent_title] => 'Medicine for prevention of and treatment for amyloidosis'
[patent_app_type] => utility
[patent_app_number] => 10/514335
[patent_app_country] => US
[patent_app_date] => 2003-05-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 3958
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0134/20060134228.pdf
[firstpage_image] =>[orig_patent_app_number] => 10514335
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/514335 | Medicine for prevention of and treatment for amyloidosis | May 12, 2003 | Abandoned |
Array
(
[id] => 5808309
[patent_doc_number] => 20060094664
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-05-04
[patent_title] => 'Deoxycholic acid derivatives for the treatment of acute dysfunctions of portal and hepatic venous circulation'
[patent_app_type] => utility
[patent_app_number] => 10/512856
[patent_app_country] => US
[patent_app_date] => 2003-05-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3191
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0094/20060094664.pdf
[firstpage_image] =>[orig_patent_app_number] => 10512856
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/512856 | Deoxycholic acid derivatives for the treatment of acute dysfunctions of portal and hepatic venous circulation | May 8, 2003 | Abandoned |
Array
(
[id] => 7193586
[patent_doc_number] => 20050163853
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-07-28
[patent_title] => 'Novel biomaterials their preparation and use'
[patent_app_type] => utility
[patent_app_number] => 10/511075
[patent_app_country] => US
[patent_app_date] => 2003-04-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12606
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0163/20050163853.pdf
[firstpage_image] =>[orig_patent_app_number] => 10511075
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/511075 | Novel biomaterials their preparation and use | Apr 16, 2003 | Abandoned |
Array
(
[id] => 5715192
[patent_doc_number] => 20060078555
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-04-13
[patent_title] => 'Intraventricular hemorrhage thrombolysis'
[patent_app_type] => utility
[patent_app_number] => 10/509694
[patent_app_country] => US
[patent_app_date] => 2003-03-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 17068
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0078/20060078555.pdf
[firstpage_image] =>[orig_patent_app_number] => 10509694
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/509694 | Intraventricular hemorrhage thrombolysis | Mar 28, 2003 | Abandoned |
Array
(
[id] => 7142995
[patent_doc_number] => 20050118269
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-06-02
[patent_title] => 'External preparation for wounds'
[patent_app_type] => utility
[patent_app_number] => 10/507522
[patent_app_country] => US
[patent_app_date] => 2003-03-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6143
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0118/20050118269.pdf
[firstpage_image] =>[orig_patent_app_number] => 10507522
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/507522 | External preparation for wounds | Mar 11, 2003 | Issued |
Array
(
[id] => 6911787
[patent_doc_number] => 20050175545
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-08-11
[patent_title] => 'Formulation for inhalation comprising a glucocorticoid and a beta 2-adrenoreceptor agonist'
[patent_app_type] => utility
[patent_app_number] => 10/503540
[patent_app_country] => US
[patent_app_date] => 2003-02-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 17596
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0175/20050175545.pdf
[firstpage_image] =>[orig_patent_app_number] => 10503540
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/503540 | Formulation for inhalation comprising a glucocorticoid and a beta 2-adrenoreceptor agonist | Feb 3, 2003 | Abandoned |
Array
(
[id] => 7111750
[patent_doc_number] => 20050209206
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-09-22
[patent_title] => 'Pharmaceutical formulation comprising an androstane derivative and a solubilising agent in an aqueous liquid carrier'
[patent_app_type] => utility
[patent_app_number] => 10/503000
[patent_app_country] => US
[patent_app_date] => 2003-02-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 10940
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0209/20050209206.pdf
[firstpage_image] =>[orig_patent_app_number] => 10503000
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/503000 | Pharmaceutical formulation comprising an androstane derivative and a solubilising agent in an aqueous liquid carrier | Feb 3, 2003 | Abandoned |
Array
(
[id] => 239612
[patent_doc_number] => 07592329
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-09-22
[patent_title] => 'Crystalline complexes of fluticasone-2-furoate'
[patent_app_type] => utility
[patent_app_number] => 10/503114
[patent_app_country] => US
[patent_app_date] => 2003-02-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 36
[patent_figures_cnt] => 36
[patent_no_of_words] => 23501
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/592/07592329.pdf
[firstpage_image] =>[orig_patent_app_number] => 10503114
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/503114 | Crystalline complexes of fluticasone-2-furoate | Feb 3, 2003 | Issued |
Array
(
[id] => 7200332
[patent_doc_number] => 20050164996
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-07-28
[patent_title] => 'Pharmaceutical formulation comprising an aqueous suspension of an androstane derivative for the treatment of inflammatory and allergic conditions'
[patent_app_type] => utility
[patent_app_number] => 10/502902
[patent_app_country] => US
[patent_app_date] => 2003-02-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 9577
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0164/20050164996.pdf
[firstpage_image] =>[orig_patent_app_number] => 10502902
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/502902 | Pharmaceutical formulation comprising an aqueous suspension of an androstane derivative for the treatment of inflammatory and allergic conditions | Feb 3, 2003 | Abandoned |
Array
(
[id] => 5894322
[patent_doc_number] => 20060002861
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-01-05
[patent_title] => 'Pharmaceutical compositions comprising 17alpha-furanylesters of 17beta-carbothiate androstanes with a muscarinic receptor antagonist'
[patent_app_type] => utility
[patent_app_number] => 10/502966
[patent_app_country] => US
[patent_app_date] => 2003-02-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 11957
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0002/20060002861.pdf
[firstpage_image] =>[orig_patent_app_number] => 10502966
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/502966 | Pharmaceutical compositions comprising 17alpha-furanylesters of 17beta-carbothiate androstanes with a muscarinic receptor antagonist | Feb 3, 2003 | Abandoned |
Array
(
[id] => 6982775
[patent_doc_number] => 20050152845
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-07-14
[patent_title] => 'Amorphous fluticasone 2-furoate, pharmaceutical compositions thereof and its conversion to the crystalline unsolvated form'
[patent_app_type] => utility
[patent_app_number] => 10/503394
[patent_app_country] => US
[patent_app_date] => 2003-02-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 12737
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0152/20050152845.pdf
[firstpage_image] =>[orig_patent_app_number] => 10503394
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/503394 | Amorphous fluticasone 2-furoate, pharmaceutical compositions thereof and its conversion to the crystalline unsolvated form | Feb 3, 2003 | Abandoned |
Array
(
[id] => 7098488
[patent_doc_number] => 20050130947
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-06-16
[patent_title] => 'Formulations for inhalation'
[patent_app_type] => utility
[patent_app_number] => 10/503396
[patent_app_country] => US
[patent_app_date] => 2003-02-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 9905
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0130/20050130947.pdf
[firstpage_image] =>[orig_patent_app_number] => 10503396
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/503396 | Formulations for inhalation | Feb 3, 2003 | Abandoned |
Array
(
[id] => 7020088
[patent_doc_number] => 20050222107
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-10-06
[patent_title] => 'Novel process'
[patent_app_type] => utility
[patent_app_number] => 10/502866
[patent_app_country] => US
[patent_app_date] => 2003-02-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8949
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0222/20050222107.pdf
[firstpage_image] =>[orig_patent_app_number] => 10502866
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/502866 | Novel process | Feb 2, 2003 | Abandoned |
Array
(
[id] => 7256710
[patent_doc_number] => 20050143388
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-06-30
[patent_title] => 'Nitric oxide donors for treatment of disease and injury'
[patent_app_type] => utility
[patent_app_number] => 10/500694
[patent_app_country] => US
[patent_app_date] => 2003-01-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 18515
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0143/20050143388.pdf
[firstpage_image] =>[orig_patent_app_number] => 10500694
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/500694 | Nitric oxide donors for treatment of disease and injury | Jan 5, 2003 | Abandoned |
Array
(
[id] => 5700630
[patent_doc_number] => 20060217315
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-09-28
[patent_title] => 'Method of controlled ovarian hyperstimulation and pharmaceutical kit for use in such method'
[patent_app_type] => utility
[patent_app_number] => 10/499505
[patent_app_country] => US
[patent_app_date] => 2002-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6510
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0217/20060217315.pdf
[firstpage_image] =>[orig_patent_app_number] => 10499505
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/499505 | Method of controlled ovarian hyperstimulation and pharmaceutical kit for use in such method | Dec 19, 2002 | Abandoned |